Cardiometabolic Risks During Anabolic Hormone Supplementation in Older Men

There is little prospective information on the cardiometabolic risks of testosterone and growth hormone (GH) replacement therapy to youthful levels during aging. We conducted a double-masked, partially placebo controlled study in 112 men 65–90 years-old. Transdermal testosterone (5g-vs-10g/day) usin...

Descripción completa

Detalles Bibliográficos
Autores principales: He, J., Bhasin, S, Binder, E.F., Yarasheski, K.E., Castaneda-Sceppa, C., Schroeder, E.T., Roubenoff, R., Chou, C-P., Azen, S.P., Sattler, F.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930448/
https://www.ncbi.nlm.nih.gov/pubmed/23784898
http://dx.doi.org/10.1002/oby.20081

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930448/
https://www.ncbi.nlm.nih.gov/pubmed/23784898
http://dx.doi.org/10.1002/oby.20081

Ejemplares similares